First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma (NCT07560865)
🩺 Plain-English Summary (8th-Grade Level)
This is a single center, first-in cancer-type phase I clinical trial of FT536 for adult patients with recurrent WHO Grade 4 astrocytoma, irrespective of IDH-mutational status, for which a standard of care repeat craniotomy for gross tumor resection at time of first or second recurrence is achievable. Per this treatment schema, FT536 will be administered once intratumorally
Who can join: Review the eligibility criteria below.
Location: Elizabeth C. Neil, MD — Minneapolis, Minnesota
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Elizabeth C. Neil, MD — Minneapolis, Minnesota
📞 Contact the Study Coordinator
Phone: (612) 273-8383
Email: neile@umn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Astrocytoma
- Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma — Birmingham, Alabama
- Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma — Chicago, Illinois
- Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma — Bethesda, Maryland
Explore by condition: All Astrocytoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.